Klotho modulates electrical activity and calcium homeostasis in pulmonary vein cardiomyocytes via PI3K/Akt signalling
Authors:
- 30 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (7) , 1132-1141
Abstract
Aims: Klotho, a potential antiageing protein has remarkable cardiovascular effects, which is lower in the patients with chronic kidney disease (CKD). Chronic kidney disease increases the risk of atrial fibrillation, majorly triggered by pulmonary vein (PV) arrhythmogenesis. This study investigated whether klotho protein can modulate PV electrical activity and the underlying potential mechanisms. Methods and results: A conventional microelectrode and whole-cell patch clamp were used to investigate the action potentials and ionic currents in isolated rabbit PV tissue preparations and single cardiomyocytes before and after klotho administration. Phosphoinositide 3-kinase (PI3K)/Akt signalling was studied using western blotting. Klotho significantly reduced PV spontaneous beating rates in PV tissue preparations at 1.0 and 3.0 ng/mL (but not at 0.1 and 0.3 ng/mL). In the presence of the Akt inhibitor (10 µM), klotho (1.0 and 3.0 ng/mL) did not change PV electrical activities. Klotho (1.0 ng/mL) significantly decreased the late sodium current (INa-Late) and L-type calcium current (ICa-L), similar to the Akt inhibitor (10 µM). Western blots demonstrated that klotho (1.0 ng/mL)-treated PV cardiomyocytes had less phosphorylation of Akt (Ser473) compared with klotho-untreated cardiomyocytes. Compared with control PVs, klotho at relatively lower concentrations (0.1 and 0.3 ng/mL) significantly reduced beating rates and decreased the amplitudes of delay afterdepolarizations in CKD PVs. Conclusion: Klotho modulated PV electrical activity by inhibiting PI3K/Akt signalling, which may provide a novel insight into CKD-induced arrhythmogenesis.Keywords
Funding Information
- Ministry of Science and Technology (MOST105-2314-B-016-035-MY3, MOST105-2628-B-038-012-MY3, MOST105-2314-B-038-026, MOST105-2314-B-281-004-MY2, MOST105-2314-B-038-059-MY3, MOST108-2314-B-016-049)
- Taipei Medical University-Wan Fang Hospital (105-swf-02, 105-wf-eva-08, 105-wf-eva-14, 106-eva-02, 106-eva-06, 106-swf-01)
- Cathay General Hospital (106CGH-TMU-04)
- Chi-Mei Medical Center (107CM-TMU-04, CMNDMC10606)
- Foundation for the Development of Internal Medicine (29-02-001)
- Tri-Service General Hospital (TSGH-C108-008-S01)
- National Defense Medical Center (MAB-107-044)
This publication has 20 references indexed in Scilit:
- Bone Marrow and Plasma FGF-23 in Heart Failure Patients: Novel Insights Into the Heart–Bone AxisESC Heart Failure, 2019
- Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillationCytokine, 2018
- Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levelsScientific Reports, 2018
- New Insights into the Mechanism of Action of Soluble KlothoFrontiers in Endocrinology, 2017
- Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stressCell Death & Disease, 2017
- Potential application of klotho in human chronic kidney diseaseBone, 2017
- Control of Cardiac Repolarization by Phosphoinositide 3-Kinase Signaling to Ion ChannelsCirculation Research, 2015
- Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial FibrillationCirculation, 2014
- α-Klotho as a Regulator of Calcium HomeostasisScience, 2007
- Sinoatrial Node Dysfunction and Early Unexpected Death of Mice With a Defect of klotho Gene ExpressionCirculation, 2004